Literature DB >> 4105209

Amantadine in depression.

S Vale, M A Espejel, J C Dominguez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4105209     DOI： 10.1016/s0140-6736(71)90153-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Reconsidering anhedonia in depression: lessons from translational neuroscience.

Authors:  Michael T Treadway; David H Zald
Journal:  Neurosci Biobehav Rev       Date:  2010-07-11       Impact factor: 8.989

Review 2.  Review of pharmacological treatment in mood disorders and future directions for drug development.

Authors:  Xiaohua Li; Mark A Frye; Richard C Shelton
Journal:  Neuropsychopharmacology       Date:  2011-09-07       Impact factor: 7.853

3.  Amantadine-induced aggressiveness.

Authors:  M Rizzo; P L Morselli
Journal:  Br Med J       Date:  1972-07-01

4.  Urinary excretion of amantadine by the elderly.

Authors:  C Montanari; P Ferrari; A Bavazzano
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

Review 5.  Immunity, inflammation, and bipolar disorder: diagnostic and therapeutic implications.

Authors:  Nora Hamdani; Raphael Doukhan; Ozlem Kurtlucan; Ryad Tamouza; Marion Leboyer
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

Review 6.  New paradigms for treatment-resistant depression.

Authors:  Carlos Zarate; Ronald S Duman; Guosong Liu; Simone Sartori; Jorge Quiroz; Harald Murck
Journal:  Ann N Y Acad Sci       Date:  2013-07       Impact factor: 5.691

Review 7.  Advances in the treatment of anxiety: targeting glutamate.

Authors:  Asher B Simon; Jack M Gorman
Journal:  NeuroRx       Date:  2006-01

8.  Bipolar disorder: involvement of signaling cascades and AMPA receptor trafficking at synapses.

Authors:  Jing Du; Jorge Quiroz; Peixiong Yuan; Carlos Zarate; Husseini K Manji
Journal:  Neuron Glia Biol       Date:  2004-08

Review 9.  Rapid-acting glutamatergic antidepressants: the path to ketamine and beyond.

Authors:  John H Krystal; Gerard Sanacora; Ronald S Duman
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

10.  Cortical inhibitory and excitatory correlates of depression severity in children and adolescents.

Authors:  Charles P Lewis; Paul A Nakonezny; Stephanie H Ameis; Jennifer L Vande Voort; Mustafa M Husain; Graham J Emslie; Zafiris J Daskalakis; Paul E Croarkin
Journal:  J Affect Disord       Date:  2015-10-28       Impact factor: 4.839
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.